Inventor
XIANQI KONG
Inventor
CA
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
A61KPreparations for medical, dental or toiletry purposes16%
C07BGeneral methods of organic chemistry15%
C07CAcyclic or carbocyclic compounds10%
C07HSugars10%
C07DHeterocyclic compounds9%
C07KPeptides8%
C07JSteroids5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
12,595,260Stable heavy isotopes in amide functional groups and uses thereof202612,552,823Glucosamine derivatives and pharmaceutical uses thereof202612,459,888Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof202512,403,129Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular disease202512,365,675Stable heavy isotopes in amide functional groups and uses thereof202512,338,205Crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acid202512,312,378Glucosamine derivatives for the prevention or treatment of joint disorders202511,970,490Stable heavy isotopes in amide functional groups and uses thereof202411,725,020Prodrugs of a CDK inhibitor for treating cancers202311,718,636Glucosamine derivatives for the prevention or treatment of joint disorders202311,608,314Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof202311,591,358Glucosamine derivatives and pharmaceutical uses thereof202311,530,234CD73 inhibitors and pharmaceutical uses thereof202211,225,497Prodrugs of a CDK inhibitor for treating cancers202211,186,543Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to RISEN SUZHOU PHARMA TECH CO LTD (15)· patent assignee history
2021–2025Based in CN· patent location history
2022–2026Patents assigned to SHANGHAI JUNSHI BIOSCIENCES CO LTD (5)· patent assignee history
2022–2026Based in CA· patent location history
2023Patents assigned to SHANGHAI JUNSHL BIOSCIENCES CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RISEN SUZHOU PHARMA TECH CO LTD | 15 | 2021–2026 |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 5 | 2022–2026 |
| SHANGHAI JUNSHL BIOSCIENCES CO LTD | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| CA | 12 | 2022–2026 |
| CN | 3 | 2021–2025 |